Free Trial

Soleno Therapeutics (SLNO) SEC Filings & 10K Form

Soleno Therapeutics logo
$57.78 +3.15 (+5.77%)
(As of 11/22/2024 ET)

Recent Soleno Therapeutics SEC Filings

DateFilerForm TypeView
11/19/2024
8:44 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
11/14/2024
8:36 AM
Avoro Capital Advisors LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
11/12/2024
8:33 AM
Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:06 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/21/2024
3:30 PM
Abingworth Bioventures VII LP (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/15/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/10/2024
3:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/03/2024
4:53 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:55 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:02 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:03 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
09/10/2024
5:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:37 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
08/30/2024
5:33 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:34 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:35 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:36 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
6:36 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:14 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2024
6:16 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
5:16 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
5:18 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:55 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:18 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:54 PM
Soleno Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:00 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:02 PM
Soleno Therapeutics (Filer)
Form 424B5
07/19/2024
4:04 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:00 AM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:01 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
8:01 AM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:02 AM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:02 AM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
8:03 AM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
07/19/2024
8:04 AM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:56 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:58 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:58 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
5:00 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:13 PM
Melincoff Gwen A (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
3:17 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:49 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:50 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:51 PM
Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:52 PM
Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
7:46 PM
Harris William G (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:29 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
6:11 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:28 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
12:07 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13D/A
05/01/2024
12:10 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:53 PM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
4:54 PM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2024
4:06 PM
Soleno Therapeutics (Filer)
Form ARS
04/22/2024
3:31 PM
Soleno Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:15 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
8:36 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:37 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:39 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:40 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:06 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:35 PM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
02/07/2024
7:01 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:57 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:42 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:44 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:47 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:31 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:35 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:36 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:37 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:16 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
5:00 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
6:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:09 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
8:32 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:32 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:46 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
3:53 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:17 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
6:05 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

12/11/2023
6:21 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
7:41 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:02 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:03 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:04 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:06 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:50 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:51 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:52 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLNO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners